Pfizer and Valneva Secure EMA Validation for Lyme Vaccine
NEW YORK and LYON, France, August 14, 2026 Pfizer Inc. and Valneva SE announced that the European Medicines Agency...
OspA
Advertisement
Can-Fite Launches Phase 2 Piclidenoson Trial for Lowe Syndrome
RAMAT GAN, Israel, Aug. 3, 2026 Can-Fite BioPharma Ltd. has launched its first clinical development program evaluating Piclidenoson for...
Opus Genetics Completes Enrollment in OPGx-LCA5 Phase 3 Trial
RESEARCH TRIANGLE PARK, N.C., Aug. 3, 2026 Opus Genetics, Inc. has completed patient enrollment in its registrational Phase 3...
Tonix Pharmaceuticals Receives FDA Alignment for TNX-4800 Phase 2 Trial
BERKELEY HEIGHTS, N.J., Aug. 3, 2026 Tonix Pharmaceuticals Holding Corp. announced that it has received official Type C meeting...
Advertisement
